Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06413277 · ClinicalTrials.gov registry record
Targeting the Conus Medullaris With ECAP-Controlled Closed-Loop SCS for Treatment of Chronic Pelvic Pain: HOPE Trial
A clinical trial of Chronic Pelvic Pain and Pudendal Neuralgia, sponsored by Ainsworth Institute of Pain Management.
- Recruiting
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT06413277: Recruiting study of Chronic Pelvic Pain and Pudendal Neuralgia, sponsored by Ainsworth Institute of Pain Management.
NCT06413277 is a study of Chronic Pelvic Pain and Pudendal Neuralgia that is actively recruiting participants, run by Ainsworth Institute of Pain Management. The registered enrollment target is 20 participants, below the 334-participant average among 8 other Chronic Pelvic Pain trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06413277, a study of Chronic Pelvic Pain and Pudendal Neuralgia, is actively recruiting participants, sponsored by Ainsworth Institute of Pain Management.
- RECRUITING
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of the study is to evaluate the effectiveness of using ECAP (electrically evoked compound action potential)-controlled CL (closed-loop) SCS (spinal cord stimulation) to treat chronic pelvic pain by stimulating an area in the spine called the conus medullaris (the lowermost tapering extremity of the spinal cord).
Primary Outcome
Pelvic Pain Reduction will be evaluated using the Visual Analog Scale (VAS) by comparing baseline VAS Scores to 3-, 6-, and 12- month post ECAP CL-SCS Implant VAS Scores.
Conditions Studied
Interventions
- DEVICE Saluda Evoke Smart SCS System
Study Locations (1)
New York
- Ainsworth Institute of Pain Management - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2024-02-05 |
| Est. Completion | 2027-01-01 |
What NCT06413277 shows while recruiting
NCT06413277 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 334-participant average among 8 other Chronic Pelvic Pain trials with a reported enrollment target (94% lower).
The record links to 2 conditions, with Chronic Pelvic Pain appearing as the primary indexed condition, and to 1 intervention - of which Saluda Evoke Smart SCS System is the first listed.
NCT06413277 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06413277 about?
NCT06413277 is a clinical study titled "Targeting the Conus Medullaris With ECAP-Controlled Closed-Loop SCS for Treatment of Chronic Pelvic Pain: HOPE Trial". The aim of the study is to evaluate the effectiveness of using ECAP (electrically evoked compound action potential)-controlled CL (closed-loop) SCS (spinal cord stimulation) to treat chronic pelvic pain by stimulating an area in the spine called the conus medullaris (the lowermost tapering extremity...
What is the current status of trial NCT06413277?
This trial is currently recruiting. The enrollment target is 20 participants. The study started on 2024-02-05. Estimated completion is 2027-01-01.
What conditions does trial NCT06413277 study?
This clinical trial studies the following conditions: Chronic Pelvic Pain, Pudendal Neuralgia.
What interventions are being tested in trial NCT06413277?
The interventions under investigation include: Saluda Evoke Smart SCS System (DEVICE).
Who is sponsoring clinical trial NCT06413277?
This trial is sponsored by Ainsworth Institute of Pain Management, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06413277 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Pelvic Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06413277's enrollment target sits among peer trials
20 9th of 8 the lowest of 8 other Chronic Pelvic Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Pelvic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
NSAID Use for Treating Dysmenorrhea and Preventing Chronic Pelvic Pain (NSAID HEAL)
RECRUITING · Phase 4
-
National Program to Overcome Pelvic Pain studY (POPPY)
RECRUITING · NA
-
Brief Pain Exposure Therapy (BPET) For Nociplastic Pain
RECRUITING · NA
-
Vaginal Photobiomodulation for Chronic Pelvic Pain
RECRUITING · Phase 2
-
Effects of Epigenetic Regulation in Chronic Pelvic Pain Syndrome
ACTIVE NOT RECRUITING
-
Global Study of Women's Health
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI